Back to search results

Ozone Treatment in Paresthesia (Numbness, Tingling) Secondary to Chemotherapy-induced Peripheral Neuropathy

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Chemotherapy Induced Peripheral Neuropathy (CIPN) · Paresthesia · Numbness · Tingling

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Dr. Negrín University Hospital, Las Palmas, Las Palmas, Spain

    Contact: Study coordinator (Bernardino Clavo, MD, PhD) · bernardinoclavo@gmail.com · 34928449278
    Contact: Study coordinator (Francisco Rodríguez-Esparragón, BSc, PhD) · afrodesp@gmail.com · 34928449288
    Contact: Principal Investigator (Bernardino Clavo, MD, PhD)
    Contact: Principal Investigator (Francisco Rodríguez-Esparragón, BSc, PhD)
Study leads

  • Bernardino Clavo, MD, PhD

    Study Chair

    Hospital Universitario de Gran Canaria Dr. Negrín, (FIISC), Las Palmas, Spain

  • Francisco Rodríguez-Esparragón, BSc, PhD

    Study Director

    Hospital Universitario de Gran Canaria Dr. Negrín, (FIISC), Las Palmas, Spain

  • Himar Fabelo, BSc, PhD

    Principal Investigator

    Hospital Universitario de Gran Canaria Dr. Negrín, (FIISC), Las Palmas, Spain

  • Gustavo M Callicó, Prof, PhD

    Principal Investigator

    University of Las Palmas de Gran Canaria

  • Francisco Rodríguez-Esparragón, BSc, PhD

    Principal Investigator

    Hospital Universitario de Gran Canaria Dr. Negrín, (FIISC), Las Palmas, Spain

  • Bernardino Clavo, MD, PhD

    Principal Investigator

    Hospital Universitario de Gran Canaria Dr. Negrín, (FIISC), Las Palmas, Spain

View source on ClinicalTrials.gov(opens in a new tab)